Child and Adolescent Psychiatry and Mental Health Drug Monitoring in Child and Adolescent Psychiatry for Improved Efficacy and Safety of Psychopharmacotherapy

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutisches Drug-Monitoring (TDM)

  2009cited by this paper
• Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring

  2008cited by this paper
• A three-country comparison of psychotropic medication prevalence in youth

  2008cited by this paper
• Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications

  2008cited by this paper
• Ethical issues in psychopharmacology of children and adolescents

  2008cited by this paper
• CYP2D6 Phenotype Prediction From Genotype: Which System Is the Best?

  2008cited by this paper
• The EU-regulation on medicinal products for paediatric use

  2007cited by this paper
• Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial

  2007cited by this paper
• Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.

  2007cited by this paper
• Industrieunabhängige Forschung an Kindern und die 12. Novelle des Arzneimittelgesetzes

  2007cited by this paper
• Antidepressant Use in Children and Adolescents in Germany

  2006cited by this paper
• Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.

  2006cited by this paper
• The Relevance of Pharmacokinetic Studies in Designing Efficacy Trials in Juvenile Major Depression

  2006cited by this paper
• Antidepressant prevalence for youths: a multi‐national comparison

  2006cited by this paper
• Treatment-Emergent Adverse Events from Selective Serotonin Reuptake Inhibitors by Age Group: Children versus Adolescents

  2006cited by this paper
• Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.

  2005cited by this paper
• Bipolar disorder in children and adolescents: international perspective on epidemiology and phenomenology.

  2005cited by this paper
• Clinical Consequences of Cytochrome P450 2C9 Polymorphisms

  2005cited by this paper
• The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.

  2004cited by this paper
• Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

  2004cited by this paper
• Children in need of medical innovation

  2004cited by this paper
• Do child psychiatrists in Germany diagnose bipolar disorders in children and adolescents? Results from a survey.

  2004cited by this paper
• The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

  2004cited by this paper
• Developmental pharmacology--drug disposition, action, and therapy in infants and children.

  2003cited by this paper
• Pharmacogenomics--drug disposition, drug targets, and side effects.

  2003cited by this paper
• The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics.

  2002cited by this paper
• Risperidone in children with autism and serious behavioral problems.

  2002cited by this paper
• Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test

  2001cited by this paper
• CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages

  2001cited by this paper
• Survey of unlicensed and off label drug use in paediatric wards in European countries

  2000cited by this paper
• Anwendung von Medikamenten außerhalb der Zulassung oder ohne Zulassung bei Kindern

  2000cited by this paper
• The CYP2C19 Enzyme Polymorphism

  2000cited by this paper
• Brain development during childhood and adolescence: a longitudinal MRI study

  1999cited by this paper
• Pharmacogenomics: translating functional genomics into rational therapeutics.

  1999cited by this paper
• Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.

  1996cited by this paper
• Human brain dopamine receptors in children and aging adults

  1987cited by this paper

• Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trial

  2025cites this paper
• Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine

  2024cites this paper
• Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study

  2022cites this paper
• Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone

  2022cites this paper
• Practical and Ethical Issues in Pediatric Psychopharmacology: Introductory Considerations

  2021cites this paper
• [Therapeutic drug monitoring to optimize psychopharmacotherapy in children and adolescents - Update and guidelines for practice].

  2021cites this paper
• Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient care

  2020cites this paper
• Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

  2018cites this paper
• Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland

  2018cites this paper
• Estudio de las alteraciones endocrinas durante el uso de psicofármacos en la infancia y adolescencia a partir de una base de datos prospectiva en atención especializada del área VI

  2018cites this paper
• Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood Disorders

  2017cites this paper
• Therapeutic Drug Monitoring in Children and Adolescents Under Pharmacotherapy With Olanzapine in Daily Clinical Practice

  2017cites this paper
• Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

  2017cites this paper
• Therapeutic drug monitoring as a measure of proactive pharmacovigilance in child and adolescent psychiatry

  2016cites this paper
• Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice

  2016cites this paper
• Quality of Care for Medicaid-Enrolled Youth with Bipolar Disorders

  2015cites this paper
• Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.

  2015cites this paper
• Experience of psychotropic drug use among young people with mental health problems

  2015cites this paper
• From Fidgeters, Footerers and Flibbertigibbets to the Medicalisation of Childhood Behaviour

  2015cites this paper
• AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

  2014cites this paper
• Special Features of Psychopharmacological Therapy in Children and Adolescents

  2014cites this paper
• Characteristics and Treatment Needs of Preadolescent Versus Adolescent Children in an Intensive Residential Treatment Program

  2014cites this paper
• The Subjective Experience of Being Medicated in Troubled Youth: A Sample from Residential Treatment

  2014cites this paper
• Psychotropic Medication Use with Troubled Children and Youth

  2014cites this paper
• Studien mit Kindern und Jugendlichen – aus medizinischer Sicht

  2014cites this paper
• Ganzheitliche Behandlung bei Adoleszentenkrisen

  2014cites this paper
• Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman

  2014cites this paper
• SENTIA: a systematic online monitoring registry for children and adolescents treated with antipsychotics

  2014influential citation
• Psychotropic Medication Use with Troubled Children and Youth

  2014cites this paper
• Safety and Pharmacokinetics of Atypical Antipsychotics in Children and Adolescents

  2013cites this paper
• The Subjective Experience of Being Medicated in Troubled Youth: A Sample from Residential Treatment

  2013cites this paper
• Concurrent reductions in psychotropic medication, assault, and physical restraint in two residential treatment programs for youth

  2013cites this paper
• The Relation Between Dosage, Serum Concentrations, and Clinical Outcome in Children and Adolescents Treated With Sertraline: A Naturalistic Study

  2013cites this paper
• Entwicklungs- und reifeabhängiges Behandlungskonzept

  2012cites this paper
• Pharmacotherapy challenges in patients with first-episode psychosis.

  2012cites this paper
• What does it mean to experience paediatric depression?: the ethics of mental health diagnosis and treatment in children and adolescents

  2012cites this paper
• Antipsychotic drug toxicology in children

  2011cites this paper
• Therapeutic Drug Monitoring in Child and Adolescent Psychiatry

  2011cites this paper
• AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

  2011cites this paper
• Therapeutic Drug Monitoring of Children and Adolescents Treated with Fluoxetine

  2011cites this paper
• Psychotropic medication use in children and adolescents in an inpatient setting.

  2011cites this paper
• Antidepressant Exposure as a Predictor of Clinical Outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) Study

  2011cites this paper
• Quetiapine in Adolescents with Non-Affective Psychotic Disorders: An Open-Label Trial

  2011cites this paper
• Off-label or Unlicensed Drug Prescriptions in Child and Adolescent Psychiatry

  2011cites this paper
• Safeguarding children's rights in psychopharmacological research: ethical and legal issues.

  2010influential citation
• Serum Concentrations, Therapeutic Response and Side Effects in Children and Adolescents with Impulsive-Aggressive Symptoms during Risperidone Therapy

  2009cites this paper
• Vii. Referencias

  year unknowncites this paper